Newron Pharmaceuticals Spa Stock Fundamentals
| NWPHFDelisted Stock | USD 2.10 0.00 0.00% |
Newron Pharmaceuticals SpA fundamentals help investors to digest information that contributes to Newron Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Newron OTC Stock. The fundamental analysis module provides a way to measure Newron Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Newron Pharmaceuticals otc stock.
Newron |
Newron Pharmaceuticals SpA OTC Stock Return On Equity Analysis
Newron Pharmaceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Newron Pharmaceuticals Return On Equity | -8.4 |
Most of Newron Pharmaceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Newron Pharmaceuticals SpA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Newron Pharmaceuticals SpA has a Return On Equity of -8.398. This is 64.96% lower than that of the Healthcare sector and 76.97% lower than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
Newron Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Newron Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Newron Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Newron Pharmaceuticals competition to find correlations between indicators driving Newron Pharmaceuticals's intrinsic value. More Info.Newron Pharmaceuticals SpA is considered to be number one stock in return on equity category among related companies. It is considered to be number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Newron Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Newron Pharmaceuticals' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Newron Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Newron Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Newron Pharmaceuticals' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Newron Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Newron Pharmaceuticals by comparing valuation metrics of similar companies.Newron Pharmaceuticals is currently under evaluation in return on equity category among related companies.
Newron Fundamentals
| Return On Equity | -8.4 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | (2.44) % | |||
| Operating Margin | (1.84) % | |||
| Current Valuation | 34.92 M | |||
| Shares Outstanding | 17.85 M | |||
| Shares Owned By Insiders | 4.96 % | |||
| Shares Owned By Institutions | 7.26 % | |||
| Price To Earning | (12.02) X | |||
| Price To Book | 3.89 X | |||
| Price To Sales | 6.33 X | |||
| Revenue | 5.76 M | |||
| Gross Profit | 5.76 M | |||
| EBITDA | (11.76 M) | |||
| Net Income | (14.9 M) | |||
| Cash And Equivalents | 21.91 M | |||
| Cash Per Share | 1.23 X | |||
| Total Debt | 42.54 M | |||
| Debt To Equity | 3.10 % | |||
| Current Ratio | 7.90 X | |||
| Book Value Per Share | (0.29) X | |||
| Cash Flow From Operations | (11.45 M) | |||
| Earnings Per Share | (0.88) X | |||
| Number Of Employees | 25 | |||
| Beta | 0.61 | |||
| Market Capitalization | 37.48 M | |||
| Total Asset | 50.49 M | |||
| Retained Earnings | (13 M) | |||
| Working Capital | 32 M | |||
| Current Asset | 38 M | |||
| Current Liabilities | 6 M | |||
| Net Asset | 50.49 M |
About Newron Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Newron Pharmaceuticals SpA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Newron Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Newron Pharmaceuticals SpA based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy. Newron Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 23 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Newron Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Newron Pharmaceuticals' short interest history, or implied volatility extrapolated from Newron Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Newron Pharmaceuticals information on this page should be used as a complementary analysis to other Newron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Newron OTC Stock
If you are still planning to invest in Newron Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Newron Pharmaceuticals' history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |